Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
Humana Inc. (HUM) reported strong 1Q23 earnings with a GAAP EPS of $9.87, up from $7.29 in 1Q22. Adjusted EPS rose to $9.38 from $7.81, driven by robust membership growth in the individual Medicare Advantage sector, which is projected to grow by at least 775,000 members, a 17% increase year-over-year. The company raised its FY 2023 EPS guidance to 'at least $27.88' on a GAAP basis and 'at least $28.25' adjusted. Total revenues for 1Q23 reached $26.74 billion, up from $23.97 billion a year earlier, supported by favorable inpatient utilization trends. Humana's operating cash flow showed significant improvement, reaching $6.69 billion, largely due to adjustments in premium payment timings.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, scheduled for payment on July 28, 2023, to shareholders of record as of the close of business on June 30, 2023. This dividend reflects the company's commitment to returning value to its shareholders while supporting its mission to improve healthcare for its members. Humana continues to focus on integrated care solutions, including in-home services and data analytics, which aim to enhance health outcomes and reduce costs. The company remains dedicated to its diverse members, including those in Medicare and military service.
Humana Inc. (NYSE: HUM) and the University of North Florida (UNF) are expanding the Meals on Wings program to the University of Kentucky and Lehman College. This initiative aims to combat food insecurity among older adults by providing meal assistance. The program addresses malnutrition, which affects nearly one in 12 seniors, potentially worsening chronic conditions and overburdening healthcare systems. Beginning summer 2023, the program will deliver two meals weekly to over 100 older adults in Kentucky and 30 seniors in the Bronx. This expansion reflects Humana's commitment to enhance meal security for vulnerable populations in Florida, Kentucky, and New York.
Humana Inc. (NYSE: HUM) announced a new $40 million investment, raising its total commitment to affordable housing to
Humana Inc. (NYSE: HUM) is donating
CEO Bruce Broussard expressed the profound impact of the tragedy on the community, emphasizing the need for healing and recovery. The funding will assist organizations that provide equitable access to mental health services and trauma support, reflecting the Humana Foundation's commitment to health equity.
A Community Crisis Support Line has been activated, offering 24/7 professional emotional support for all U.S. residents. This initiative aligns with Humana's broader mission to foster health equity and community well-being.
On April 10, 2023, Humana (NYSE: HUM) announced the appointment of Dr. Billy Oglesby as the Humana Dean of the College of Population Health at Thomas Jefferson University. This role was made possible through a $15 million donation aimed at improving community health and health equity, particularly for marginalized populations in Greater Philadelphia. Dr. Oglesby, an experienced population health strategist, aims to leverage this partnership to advance healthcare quality and patient safety. His past accomplishments include launching quality improvement programs and establishing community health initiatives. The significant investment reflects Humana's commitment to transforming health outcomes and addressing social determinants of health.